Hangzhou Diagens Biotechnology's (HKG:2526) core product AI AutoVision obtained a Class III Medical Device Registration Certificate from China's National Medical Products Administration, according to a Friday filing with the Hong Kong bourse.
The approved indications under the certificate cover chromosome karyotype analysis for the prenatal diagnosis for birth defects using amniotic fluid samples and assisted reproduction using peripheral blood samples.